| Joleen Crook Frideres, LMHC | |
|
117 E Call St Ste 5, Algona, IA 50511-2444 | |
| (515) 341-5800 | |
| Not Available |
| Full Name | Joleen Crook Frideres |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 117 E Call St Ste 5, Algona, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780165282 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 089107 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joleen Crook Frideres, LMHC 117 E Call St Ste 5, Algona, IA 50511-2444 Ph: (515) 341-5800 | Joleen Crook Frideres, LMHC 117 E Call St Ste 5, Algona, IA 50511-2444 Ph: (515) 341-5800 |
News Archive
Boston Scientific Corporation today announced the start of patient enrollment in the SuperNOVA clinical trial, an international, prospective, single-arm, non-randomized trial evaluating the safety and effectiveness of the INNOVA™ Self-Expanding Bare-Metal Stent System in patients with stenosis of the superficial femoral artery (SFA) or proximal popliteal artery (PPA).
Magnetic resonance imaging (MRI) isn't just for capturing detailed images of the body's anatomy. Thanks to novel imaging reagents and technology developed by Carnegie Mellon University scientist Eric Ahrens, MRI can be used to visualize - with "exquisite" specificity - cell populations of interest in the living body. The ability to non-invasively locate and track cells, such as immune cells, will greatly aid the study and treatment of cancer, inflammation, and autoimmune diseases, as well as provide a tool for advancing clinical translation of the emerging field of cellular regenerative medicine, by tracking stem cells for example.
Bristol-Myers Squibb Company and AstraZeneca today announced results from a randomized, double-blind Phase 3 clinical study in adults with type 2 diabetes inadequately controlled on metformin therapy alone.
Carbon dioxide, an environmentally friendly solvent for dyeing and dry cleaning, may become a valuable new tool for making medical implants, according to a study at Ohio State University.
Bioengineers at UC San Diego have developed a breakthrough method for sequencing-based methylation profiling, which could help fuel personalized regenerative medicine and even lead to more efficient and cost-effective methods for studying certain diseases.
› Verified 8 days ago
Autumn Kramer, M.S. ED. Counselor Medicare: Not Enrolled in Medicare Practice Location: 107 N Harlan St Ste A, Algona, IA 50511 Phone: 515-341-6653 |